There has always been controversy around Intuitive Surgical (Nasdaq:ISRG)
and its daVinci robotic surgical system. In recent months this
controversy has reignited over allegations that device
malfunctions/adverse events are increasing and that the system is little
more than an expensive, unnecessary toy in procedures like minimally
invasive hysterectomy. Making matters worse, this has long been an
expensive stock where success has been predicated on double-digit growth
in minimally invasive surgery and Intuitive's share in the market.
Please click below for more:
http://www.investopedia.com/stock-analysis/041913/controversy-about-robotassisted-surgery-showing-intuitive-surgicals-numbers-isrg-cov-jnj-syk-mako.aspx
No comments:
Post a Comment